Oxford Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Oxford Asset Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,996	Closed	-$348K	–	622
2024 Q3	$348K	Sell	4,996 -647	-11%	-$44.4K	0.29%	126
2024 Q2	$379K	Buy	5,643 +656	+13%	+$44.2K	0.37%	94
2024 Q1	$344K	Buy	+4,987	New	+$336K	0.36%	94
2019 Q2	–	Sell	-24,523	Closed	-$587K	–	2005
2019 Q1	$587K	Sell	24,523 -54,277	-69%	-$985K	0.01%	1146
2018 Q4	$1.19M	Buy	+78,800	New	+$1.17M	0.03%	773

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oxford Asset Management's AXNX Position: Q4 2024 in Review

Oxford Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 4,996 shares — an estimated $348K sold.

Oxford Asset Management first reported a position in AXNX in Q4 2018 and held it in 5 quarters. The position peaked at $1.19M in Q4 2018. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Oxford Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Oxford Asset Management sold 4,996 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $348K.
Oxford Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
Oxford Asset Management's Axonics, Inc. Common Stock position peaked at $1.19M in Q4 2018.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Oxford Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.